Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study-Reference-Cited by-同舟云学术

Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study

Published:2014-08-02 Issue:1 Volume:14 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Char Anjali,Hopkinson Nick S,Hansell David M,Nicholson Andrew G,Shaw Emily C,Clark Samuel J,Sedgwick Philip,Wilson Robert,Jordan Simon,Loebinger Michael R

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2466-14-124.pdf

Reference17 articles.

1. Sexton P, Harrison AC: Susceptibilty to nontuberculosis mycobacterial lung disease. Eur Respir J. 2008, 31: 1322-1333.

2. Griffith DE, Aksamit T, Brown-Elliot BA, Cantanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, Fordham von Reyn C, Wallace RJ, Winthro K: An official ATS/IDSA statement: diagnosis, treatement and prevention of nontuberculosis mycobacterial diseases. Am J Respir Crit Med. 2007, 175: 162-166.

3. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society: Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax. 2000, 55: 210-218.

4. Glassroth J: Pulmonary disease due to nontuberculosis mycobacteria. Chest. 2008, 133 (1): 243-251.

5. Cowman S, Wilson R, Loebinger MR: Opportunistic mycobacterial diseases. Medicine. 2012, 40 (6): 346-348.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease;BMC Infectious Diseases;2023-11-01

2. Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease;ERJ Open Research;2022-11-10

3. Nontuberculous Mycobacterial Pulmonary Disease;Chest;2021-10

4. MicroRNA-155 Modulates Macrophages’ Response to Non-Tuberculous Mycobacteria through COX-2/PGE2 Signaling;Pathogens;2021-07-21

5. A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective;Expert Review of Respiratory Medicine;2021-02-23